Purdue Pharma is settling a lawsuit with the State of Oklahoma for $270
Oklahoma Attorney General Mike Hunter filed a lawsuit against Purdue Pharma
and three other opioid pharmaceutical companies in 2017. Mike Hunter sued
these companies’ because of misleading marketing campaigns over the
previous decade, which helped fuel the state’s opioid epidemic.
“The addiction crisis facing our state and nation is a clear and present
danger,” Mike Hunter said
A $200 million endowment will be used for treating the ongoing addiction
epidemic that is nationwide. Purdue Pharma also settled to not promote
opioids in Oklahoma, including employing or contracting with sales
representatives to health care providers in Oklahoma.
It was said that 50% of Oklahomans who died from a drug overdose in 2018
were attributed to a pharmaceutical drug.
An initial payment of $102.5 million will be made to the endowment, to be
utilized by Oklahoma State University Center for Health Sciences Center for
Recovery and Wellness for treating pain and addiction, according to Mike
Hunter’s statement. On Jan 1, 2020, the endowment will receive an annual
$15 million payment for the duration of 5 years. During the same timeframe,
it will receive ongoing contributions of addiction treatment medicine,
valued at $20 million
*Additional Details *
– $12.5 million will go towards providing funds to directly abate and
address the opioid epidemic’s effects in Oklahoma’s cities and counties.
– Purdue will also make a $60 million payment to offset all litigation
costs up to this point.
– Purdue will not promote opioids in Oklahoma, including employing or
contracting with sales representatives to health care providers in
Attorney General Hunter Announces Historic $270 Million Settlement with
Purdue Pharma, $200 Million to Establish Endowment for OSU Center for
Wellness. Oklahoma City, OK; March 27, 2019: Oklahoma Attorney General’s
Accessed March 26, 2019.